First Oral Alzheimer’s Pill Shows Promise for High-Risk Patients
A new Alzheimer’s drug pill has shown encouraging results in a late-stage trial for people with a high genetic risk of the disease. The pill, called ALZ-801 (valiltramiprosate), is designed for people who carry two copies of the APOE4 gene. This group is known to have the highest chance of developing Alzheimer’s and often declines…